(Q42468590)

1 November 2017

p63 short isoforms are found in invasive carcinomas only and not in benign breast conditions (English)

1 reference

1 November 2017

6

1 reference

1 November 2017

Luca Morandi

2

0 references

Annalisa Pession

object named as

Annalisa Pession

5

0 references

author name string

Dario de Biase

1

1 reference

1 November 2017

Roberta Degli Esposti

3

1 reference

1 November 2017

Claudia Ligorio

4

1 reference

1 November 2017

Vincenzo Eusebi

7

1 reference

1 November 2017

language of work or name

1 reference

12 March 2010

1 reference

1 November 2017

1 reference

1 November 2017

456

1 reference

1 November 2017

4

1 reference

1 November 2017

395-401

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-010-0900-1

1 November 2017

0 references

cites work

Loss of p63 expression is associated with tumor progression in bladder cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00428-010-0900-1

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

21 January 2018

1 reference

12 December 2020

A dominant negative form of p63 inhibits apoptosis in a p53-independent manner

1 reference

12 December 2020

Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples

1 reference

12 December 2020

Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51

1 reference

12 December 2020

E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior

1 reference

12 December 2020

p63 expression in normal, hyperplastic and malignant breast tissues

1 reference

12 December 2020

p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma

1 reference

12 December 2020

Pattern of p63 expression in squamous cell carcinoma of the oral cavity.

1 reference

12 December 2020

Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray

1 reference

12 December 2020

Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation.

1 reference

12 December 2020

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

12 December 2020

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas

1 reference

12 December 2020

p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation

1 reference

12 December 2020

The p53/p63/p73 family of transcription factors: overlapping and distinct functions.

1 reference

12 December 2020

p63 and epithelial biology

1 reference

12 December 2020

From p63 to p53 across p73.

1 reference

12 December 2020

p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast

1 reference

12 December 2020

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

1 reference

12 December 2020

p63 expression profiles in human normal and tumor tissues

1 reference

12 December 2020

10.1007/S00428-010-0900-1

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference